A phase I/II, open-label, randomised study of nintedanib plus ...
†Present address: Novartis Pharma AG, Basel, Switzerland. © 2015 European Society for Medical Oncology. Published by Elsevier Inc. Access this article on.
Address
Tel
210-9893372
Website
Date
|
Product Description
|
Supplier
|
Money
|
Quantity
|
Weight
|
---|
pharmanel Contacts: Tel: 210-9893372 Website: pharmanel.gr
pharmanel's website is pharmanel.gr